Citadel Advisors’s AGF US Market Neutral Anti-Beta Fund BTAL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q1
– Sell
-200
Closed -$3.7K – 14528
2024
Q4
$3.7K Buy
200
+100
+100% +$1.92K ﹤0.01% 13982
2024
Q3
$1.96K Buy
+100
New +$1.99K ﹤0.01% 13793

Other funds holding BTAL

Citadel Advisors's BTAL Position: Q2 2026 in Review

Citadel Advisors opened a new position in AGF US Market Neutral Anti-Beta Fund (BTAL) in Q2 2026: 114,285 shares worth $1.27M. The stake represents ﹤0.01% of the portfolio and ranks #7602 among its holdings. This is a return to the name: Citadel Advisors previously reported a position in BTAL as recently as Q3 2025.

Citadel Advisors first reported a position in BTAL in Q2 2016 and has held it in 14 quarters since. The position peaked at $8.28M in Q3 2020. 93 funds tracked by Wall St. Rank hold BTAL as of Q2 2026.

  • Citadel Advisors held 114,285 shares of AGF US Market Neutral Anti-Beta Fund worth $1.27M as of Q2 2026.
  • AGF US Market Neutral Anti-Beta Fund was a new Citadel Advisors position in Q2 2026.
  • AGF US Market Neutral Anti-Beta Fund made up ﹤0.01% of Citadel Advisors's portfolio in Q2 2026, its #7602 holding.
  • Citadel Advisors first reported a position in AGF US Market Neutral Anti-Beta Fund in Q2 2016 and has held it in 14 quarters since.
  • Citadel Advisors's AGF US Market Neutral Anti-Beta Fund position peaked at $8.28M in Q3 2020.
  • 93 funds tracked by Wall St. Rank held AGF US Market Neutral Anti-Beta Fund as of Q2 2026.

Based on Citadel Advisors's 13F filing for Q2 2026, filed 14 Aug 2026.